The quad screen (ie, measurement of maternal levels of beta-hCG, unconjugated estriol, alpha-fetoprotein, and inhibin A) is recommended for most pregnant women to evaluate risk of Down syndrome, trisomy 18, spina bifida, or abdominal wall defects.